U.S. FDA panel votes for Pfizer's RSV vaccine

Indonesia Berita Berita

U.S. FDA panel votes for Pfizer's RSV vaccine
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

A panel of outside advisers to the U.S. Food and Drug Administration (FDA) on Tuesday recommended Pfizer Inc's respiratory syncytial virus (RSV) vaccine, paving the way for one of the first approved RSV shots in the United States for older adults.

Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. REUTERS/Johanna GeronFeb 28 - A panel of outside advisers to the U.S. Food and Drug Administration on Tuesday recommended Pfizer Inc's

respiratory syncytial virus vaccine, paving the way for one of the first approved RSV shots in the United States for older adults. The FDA advisory committee voted 7 to 4 in favor of the drug, saying data from the clinical study conducted by the company established that the treatment was effective and safe in preventing the lower respiratory tract disease caused by RSV in 60 years and older.Our Standards:

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Pfizer, GSK face FDA panel review in race for RSV vaccinesPfizer, GSK face FDA panel review in race for RSV vaccinesThe frontrunners in a crowded race to develop the first respiratory syncytial virus (RSV) vaccine - Pfizer Inc and GSK - will face scrutiny from a panel of experts to the U.S. Food and Drug Administration this week.
Baca lebih lajut »

FDA panel narrowly backs Pfizer's RSV vaccine for older adultsFDA panel narrowly backs Pfizer's RSV vaccine for older adultsFederal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against...
Baca lebih lajut »

FDA warns of Guillain-Barre syndrome as possible risk of Pfizer’s RSV vaccineFDA warns of Guillain-Barre syndrome as possible risk of Pfizer’s RSV vaccineGuillain-Barre syndrome, or inflammatory neuropathy, is a disorder in which the body’s immune system mistakenly attacks the nerves.
Baca lebih lajut »

FDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risksFDA advisors recommend Pfizer RSV vaccine for older adults, despite possible Guillain-Barre risks
Baca lebih lajut »

Paving the way for the world's first RSV vaccine, FDA advisers recommend shot from PfizerPaving the way for the world's first RSV vaccine, FDA advisers recommend shot from PfizerBREAKING: FDA advisers recommend that the agency approve the country’s first RSV vaccine for older people, a shot from Pfizer for adults ages 60 and up.
Baca lebih lajut »

How a Food Dehydrator Can Help You Reduce Food WasteHow a Food Dehydrator Can Help You Reduce Food WasteWe got some great ideas, tips, and tricks on how to use a food dehydrator to reduce food waste at home.
Baca lebih lajut »



Render Time: 2025-02-26 04:35:15